Agrochemical Market to Reach US$ 387.7 Billion by 2031, Driven by Innovation, Regulatory Changes, and Drone Technology: Wissen Research

Wissen Research estimates the global agrochemical market at $311.2 billion in 2026 and projects it will reach $387.7 billion by 2031. The report cites rising crop-protection needs and product innovation—including resistance-management herbicides, biologicals and precision spraying—as growth drivers, while resistance, regulation and pricing remain challenges. Global pesticide use reached 3.92 million tonnes of active ingredients in 2024, up 5% year over year; four leading companies accounted for 56% of commercial pesticide sales in 2024.

Analysis

The report’s headline market-growth figure is a weak equity signal: it combines fertilizer and crop-protection economics, so it should not be translated directly into growth for pesticide-focused businesses. The investable mechanism is product mix and share capture, not rising aggregate farm-input spend. Resistance can reward differentiated chemistry and registration scale, but generic substitution and farmer affordability limit pricing power once products lose exclusivity. BASF’s new corn herbicide is a potential 2027 share catalyst only if field efficacy and farmer adoption are demonstrated; registration itself is not revenue evidence. Bayer’s engineered nitrogen-fixation work is longer-dated optionality, not a near-term earnings driver. Biologicals may complement incumbent chemistry initially, but successful adoption could ultimately cannibalize conventional applications and favor firms able to bundle products, seed and application support.

A second-order offset: precision spraying may reduce chemical volume per acre even as treated acreage and pest pressure rise. That could shift value toward formulations, equipment and services while making volume-based pesticide forecasts less reliable. The report’s drone examples are geographically and crop-specific, so broad extrapolation is premature. The Corteva seed/genetics separation may sharpen sum-of-parts visibility, but the supplied material provides no standalone financials or transaction valuation. Treat the market forecast and company announcements as directional claims, not verified earnings upgrades.

Key Decisions for Investors

• Do not buy the agrochemical complex on the market-size forecast alone. Require company-level evidence—crop-protection sales growth, price/mix, volume, and segment margins—before underwriting a sector rerating.
• Place BASF’s Ridivex on a 2027 catalyst watchlist rather than chasing the registration headline. Reassess after launch data on adoption, efficacy, and any displacement of existing products; failure to establish field performance or a launch delay would falsify the upside case.
• Treat Bayer’s biological nitrogen collaboration as long-dated optionality, not a near-term trade. Track multi-season trial results, regulatory pathway, and commercial economics; absent those, no earnings premium is warranted.
• For Corteva, monitor the separated seed/genetics business’s standalone financials, distribution mechanics, and post-separation trading before taking a relative-value position. Without those data, the spin is a catalyst to investigate, not a basis for a price target.
• Watch for evidence that drone adoption lowers chemical use per acre at scale. If that appears across major crops, favor firms with differentiated formulations and integrated application offerings over undifferentiated active-ingredient volume exposure; broad adoption beyond the cited regions would strengthen this thesis.